Evidence map›Paper›PMID 42496815›Full record

ReviewMedical oncology (Northwood, London, England)2026

Treg-derived exosomal miR-146a orchestrates bidirectional Treg-CAF crosstalk to sustain immunosuppressive tumor microenvironments.

Haicheng Ma, Yingying Zheng, Mengmeng Pei, Yanyan Zeng, Zhenyu Zhang, Yanyan Xu, Xueting Wang, Weihang Zhang, Niannian Li, Shaoqiang Wang

Abstract readReview
In one paragraph

Review in Medical oncology (Northwood, London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haicheng MaWeifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong, P.R. China.
Yingying ZhengHealth Management Center, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong Province, China.
Mengmeng PeiHealth Management Center, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong Province, China.
Yanyan ZengDepartment of Thoracic Surgery, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong Province, China.
Zhenyu ZhangWeifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong, P.R. China.
Yanyan XuDepartment of Reproductive Medicine, The Affiliated Hospital of Shandong, Second Medical University, Shandong Second Medical University, Weifang, 261042, Shandong Province, China.
Xueting WangWeifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong, P.R. China.
Weihang ZhangWeifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong, P.R. China.
Niannian LiWeifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong, P.R. China. liniannian123liu@163.com.
Shaoqiang WangDepartment of Thoracic Surgery, Weifang People's Hospital, Shandong Second Medical University, Weifang, 261041, Shandong Province, China. rmyywsq227@sdsmu.edu.cn.

Funding

2023 Shandong Medical Association Young Talent Nurturing Project No.2023 _LC _0123Shandong Provincial Natural Science Founding No. ZR2023MH237
6 · The paper itself

Abstract

Resistance to immunotherapy is often reinforced by the resilient immunosuppressive architecture of the tumor microenvironment (TME). Although the crosstalk between regulatory T cells (Tregs) and cancer-associated fibroblasts (CAFs) is increasingly recognized as an important contributor to this resistance, the specific molecular links that sustain this interaction remain incompletely understood. This review proposes a bidirectional Treg-derived exosomal miR-146a-CAF signaling model to explain how immunosuppressive remodeling may be maintained. Current evidence suggests that activated Tregs can release exosomes enriched in miR-146a and may thereby influence the response state of recipient CAFs through signaling nodes such as TRAF6/IRAK1, NF-κB, and JAK2-STAT3. Meanwhile, CAF-derived signals may support Treg recruitment and functional maintenance. Through the secretion of chemokines and cytokines such as CCL2, CXCL12, TGF-β, and IL-6, CAFs contribute to Treg recruitment, local persistence, and suppressive function. Because these processes are currently supported largely by indirect evidence derived from different experimental models, this review integrates them into a bidirectional Treg-CAF communication framework that requires further validation, rather than presenting them as a fully established causal feedback loop. To therapeutically interrogate and potentially disrupt this putative circuit, we discuss strategies focused on blocking exosome biogenesis, neutralizing extracellular miR-146a, or disrupting downstream metabolic and signaling dependencies. These strategies are better viewed as candidate approaches for validating and intervening in this model, rather than as clinically mature targeted therapies. By distinguishing validated mechanisms from indirect evidence and testable inferences, this review aims to provide a clearer experimental framework and potential translational directions for future studies.

Indexed as

Cancer-Associated FibroblastsExosomesMicroRNAsNeoplasmsT-Lymphocytes, RegulatoryTumor MicroenvironmentAnimalsHumansSignal TransductionMicroRNAsMIRN146 microRNA, humanBidirectional crosstalkCancer-associated fibroblastsExosomal miR-146aImmunosuppressionRegulatory T cellsTumor microenvironment

Identifiers

PMID42496815
PMCPMC13400595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.